Prafulla Chandra Tiwari (Prafulla C Tiwari)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Parkinson Disease

Top Venues

Fundamental & clinical pharmacology

Annals of neurosciences

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Prafulla Chandra Tiwari, Manju J Chaudhary, Rishi Pal, Rajendra Nath
Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson's Disease in Rats. Annals of neurosciences 31 (3) (2023)
Prafulla Chandra Tiwari, Rishi Pal, Manju J Chaudhary, Rajendra Nath
Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug development research (2023)
Prafulla Chandra Tiwari, Manju J Chaudhary, Rishi Pal, Rajendra Nath
Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson's Disease in Rats. Annals of neurosciences 31 (3) (2023)
Shipra Kartik, Rishi Pal, Manju J Chaudhary, Prafulla Chandra Tiwari, Rajendra Nath, Madhu Kumar
Anti-oxidative and anti-neuroinflammatory role of Necrostatin-1s & Docosahexaenoic Acid in RIP-1-mediated neurotoxicity in MPTP Induced-Parkinson's disease model. Fundamental & clinical pharmacology (2023)
Shipra Kartik, Rishi Pal, Manju J Chaudhary, Prafulla Chandra Tiwari, Rajendra Nath, Madhu Kumar
Anti-oxidative and anti-neuroinflammatory role of Necrostatin-1s and docosahexaenoic acid in RIP-1-mediated neurotoxicity in MPTP-induced Parkinson's disease model. Fundamental & clinical pharmacology (2023)
Prafulla Chandra Tiwari, Manju J Chaudhary, Rishi Pal, Rajendra Nath
Effects of mangiferin and its combination with nNOS inhibitor 7-nitro-indazole (7-NI) in 6-hydroxydopamine (6-OHDA) lesioned Parkinson's disease rats. Fundamental & clinical pharmacology 36 (6) (2022)
Prafulla Chandra Tiwari, Manju J Chaudhary, Rishi Pal, Shipra Kartik, Rajendra Nath
Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson's Disease in Rats. Annals of neurosciences 28 (3-4) (2021)